Kaitlin M. Fitzpatrick, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leukoaraiosis | 5 | 2015 | 120 | 0.540 |
Why?
|
Brain Ischemia | 12 | 2017 | 3258 | 0.520 |
Why?
|
Stroke | 18 | 2017 | 9963 | 0.420 |
Why?
|
Leukoencephalopathies | 3 | 2015 | 238 | 0.310 |
Why?
|
Arterial Occlusive Diseases | 2 | 2015 | 793 | 0.180 |
Why?
|
Tissue Plasminogen Activator | 3 | 2015 | 1262 | 0.170 |
Why?
|
Injections, Intra-Arterial | 2 | 2014 | 193 | 0.150 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2013 | 960 | 0.140 |
Why?
|
Fabry Disease | 1 | 2016 | 90 | 0.130 |
Why?
|
Image Interpretation, Computer-Assisted | 4 | 2016 | 3328 | 0.120 |
Why?
|
Brain | 7 | 2017 | 26343 | 0.120 |
Why?
|
Meninges | 1 | 2014 | 190 | 0.110 |
Why?
|
Cerebral Angiography | 2 | 2015 | 1285 | 0.100 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2013 | 438 | 0.100 |
Why?
|
Pattern Recognition, Automated | 2 | 2016 | 996 | 0.100 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2012 | 135 | 0.100 |
Why?
|
Severity of Illness Index | 7 | 2017 | 15530 | 0.090 |
Why?
|
Subtraction Technique | 1 | 2014 | 525 | 0.090 |
Why?
|
Fibrinolytic Agents | 3 | 2015 | 2156 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2016 | 848 | 0.090 |
Why?
|
Patient Admission | 1 | 2016 | 1380 | 0.080 |
Why?
|
Microvessels | 1 | 2010 | 544 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2017 | 2736 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 8 | 2016 | 35342 | 0.060 |
Why?
|
Aspirin | 1 | 2016 | 3278 | 0.060 |
Why?
|
Cerebrovascular Circulation | 1 | 2014 | 2732 | 0.060 |
Why?
|
Aged, 80 and over | 11 | 2016 | 57683 | 0.060 |
Why?
|
Thrombolytic Therapy | 1 | 2012 | 2161 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2015 | 4455 | 0.050 |
Why?
|
Genome-Wide Association Study | 3 | 2015 | 12220 | 0.050 |
Why?
|
Aged | 16 | 2017 | 162944 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2015 | 15494 | 0.050 |
Why?
|
Middle Aged | 17 | 2017 | 213127 | 0.050 |
Why?
|
Atrial Fibrillation | 2 | 2017 | 5019 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2014 | 1973 | 0.050 |
Why?
|
Patient Selection | 1 | 2012 | 4214 | 0.040 |
Why?
|
Linear Models | 3 | 2015 | 5948 | 0.040 |
Why?
|
Cerebral Infarction | 2 | 2017 | 1007 | 0.040 |
Why?
|
Male | 17 | 2017 | 349538 | 0.040 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12242 | 0.040 |
Why?
|
Recovery of Function | 2 | 2017 | 2924 | 0.040 |
Why?
|
Female | 17 | 2017 | 379592 | 0.040 |
Why?
|
Enzyme Replacement Therapy | 1 | 2016 | 78 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2016 | 15056 | 0.030 |
Why?
|
Retrospective Studies | 7 | 2017 | 77098 | 0.030 |
Why?
|
Hypertension | 1 | 2014 | 8455 | 0.030 |
Why?
|
Case-Control Studies | 4 | 2014 | 21719 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17400 | 0.030 |
Why?
|
Infusions, Intra-Arterial | 1 | 2014 | 231 | 0.030 |
Why?
|
Age Factors | 3 | 2017 | 18355 | 0.030 |
Why?
|
Risk Factors | 6 | 2016 | 72145 | 0.030 |
Why?
|
Humans | 20 | 2017 | 742088 | 0.030 |
Why?
|
Automation | 1 | 2014 | 584 | 0.030 |
Why?
|
Treatment Outcome | 5 | 2017 | 62966 | 0.030 |
Why?
|
Boston | 2 | 2015 | 9305 | 0.030 |
Why?
|
Homocysteine | 1 | 2015 | 647 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2014 | 1525 | 0.020 |
Why?
|
Models, Anatomic | 1 | 2014 | 690 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3510 | 0.020 |
Why?
|
Carotid Artery, Internal | 1 | 2012 | 445 | 0.020 |
Why?
|
Databases, Factual | 2 | 2016 | 7716 | 0.020 |
Why?
|
Keratitis, Dendritic | 1 | 1988 | 35 | 0.020 |
Why?
|
Disability Evaluation | 1 | 2016 | 1827 | 0.020 |
Why?
|
Brain Infarction | 1 | 2010 | 296 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2015 | 1440 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3266 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2015 | 1538 | 0.020 |
Why?
|
Diffusion Tensor Imaging | 1 | 2017 | 2304 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2017 | 2585 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4211 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 2010 | 786 | 0.020 |
Why?
|
Models, Neurological | 1 | 2014 | 1771 | 0.020 |
Why?
|
Cohort Studies | 3 | 2014 | 40450 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2010 | 934 | 0.020 |
Why?
|
Simplexvirus | 1 | 1988 | 802 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39004 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2010 | 13921 | 0.020 |
Why?
|
Time Factors | 3 | 2015 | 40054 | 0.010 |
Why?
|
Prognosis | 2 | 2015 | 29010 | 0.010 |
Why?
|
Antigens, Viral | 1 | 1988 | 1034 | 0.010 |
Why?
|
Algorithms | 2 | 2015 | 13853 | 0.010 |
Why?
|
Prospective Studies | 3 | 2014 | 53187 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9846 | 0.010 |
Why?
|
Genetic Testing | 1 | 2015 | 3439 | 0.010 |
Why?
|
Image Enhancement | 1 | 2014 | 2921 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8621 | 0.010 |
Why?
|
Blood Glucose | 1 | 2016 | 6249 | 0.010 |
Why?
|
Patient Discharge | 1 | 2014 | 3300 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1988 | 3862 | 0.010 |
Why?
|
Blood Pressure | 1 | 2016 | 8541 | 0.010 |
Why?
|
Adult | 4 | 2016 | 213712 | 0.010 |
Why?
|
Logistic Models | 1 | 2014 | 13403 | 0.010 |
Why?
|
Cerebral Hemorrhage | 1 | 2010 | 2643 | 0.010 |
Why?
|
Genotype | 1 | 2013 | 12946 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 14720 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 8969 | 0.010 |
Why?
|
Sex Factors | 1 | 2010 | 10392 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2010 | 3239 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 19862 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2010 | 8925 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 56350 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20086 | 0.010 |
Why?
|
Virus Cultivation | 1 | 1988 | 92 | 0.010 |
Why?
|
Child | 1 | 2016 | 77478 | 0.000 |
Why?
|
Adolescent | 1 | 2016 | 85649 | 0.000 |
Why?
|
Evaluation Studies as Topic | 1 | 1988 | 1676 | 0.000 |
Why?
|